Ann: Telix Successfully Prices A$650M Convertible Bonds, page-69

from chatGPT:

Here’s a list of some biotech companies that have issued convertible bonds, including the year and the total amount where available:

1. Moderna, Inc.

• Year Issued: 2021
• Amount: $1.34 billion
• Details: Moderna issued convertible senior notes due in 2026 to support its ongoing research and development efforts, including vaccine development.

2. Gilead Sciences, Inc.

• Year Issued: 2020
• Amount: $3.5 billion
• Details: Gilead issued convertible senior notes to strengthen its balance sheet and fund its strategic initiatives, including potential acquisitions and R&D.

3. Illumina, Inc.

• Year Issued: 2021
• Amount: $2 billion
• Details: Illumina issued convertible senior notes to finance its acquisition of Grail and support its growth strategy.

4. Biogen Inc.

• Year Issued: 2020
• Amount: $1.5 billion
• Details: Biogen issued convertible senior notes to fund its research and commercial activities.

5. Vertex Pharmaceuticals Incorporated

• Year Issued: 2019
• Amount: $1.4 billion
• Details: Vertex issued convertible senior notes to support its ongoing research and development programs.

6. Sarepta Therapeutics, Inc.

• Year Issued: 2017
• Amount: $750 million
• Details: Sarepta issued convertible senior notes to finance its gene therapy initiatives and other research programs.

7. Neurocrine Biosciences, Inc.

• Year Issued: 2022
• Amount: $500 million
• Details: Neurocrine issued convertible senior notes to support its R&D and operational needs.

8. NantKwest, Inc.

• Year Issued: 2021
• Amount: $200 million
• Details: NantKwest issued convertible senior notes to fund its clinical trials and product development.